Li Auto Inc. May 2024 Delivery Update
May 31, 2024 22:00 ET
|
Li Auto Inc.
BEIJING, June 01, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that the Company...
DIRECT DIGITAL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Direct Digital Holdings, Inc. and Encourages Investors to Contact the Firm
May 31, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
DRCT Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Direct Digital Holdings, Inc. Class Action
May 31, 2024 19:47 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Direct Digital Holdings, Inc. (DRCT) Misled Investors Regarding its Financial Prospects
Pasinex Announces Filing of 2023 Annual Financial Results
May 31, 2024 19:34 ET
|
Pasinex Resources Limited
TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (The “Company” or “Pasinex”) announces that, further to its news releases dated April 22, 2024, May 13,...
Global Cord Blood Corporation Investors: Looming Deadline in Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
May 31, 2024 18:14 ET
|
Portnoy Law
LOS ANGELES, May 31, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses. The Portnoy Law Firm advises Global Cord Blood Corporation...
Mayfair Gold Announces that Certain Employees May Withdraw Notices of Termination under Change of Control to Continue Employment with the Company
May 31, 2024 18:00 ET
|
Mayfair Gold Corp.
MATHESON, Ontario, May 31, 2024 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) announces that it has received correspondence from all Terminating...
Johnson & Johnson submits application to the European Medicines Agency seeking approval of subcutaneous formulation of RYBREVANT®▼ (amivantamab) for the treatment of patients with EGFR-mutated non-small cell lung cancer
May 31, 2024 17:50 ET
|
Janssen Cilag International NV
Submission is supported by data from the Phase 3 PALOMA-3 study featured at the American Society of Clinical Oncology (ASCO) Annual Meeting1New formulation showed non-inferiority to intravenous...
Direct Digital Holdings Inc. Investors Notice: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
May 31, 2024 17:34 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 31, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Direct Digital Holdings...
RYBREVANT®▼ (amivantamab) plus lazertinib shows longer progression-free survival versus osimertinib in the first-line treatment of patients with high-risk EGFR-mutated non-small cell lung cancer
May 31, 2024 17:21 ET
|
Janssen Cilag International NV
Investigational chemotherapy-free regimen of amivantamab plus lazertinib addresses a significant unmet need as most patients with EGFR-mutated NSCLC have high-risk disease1 Landmark Phase 3...
Charge Enterprises, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
May 31, 2024 17:02 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 31, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Charge Enterprises (“Charge”...